The processes of angioplasty restenosis, vein graft failure, and trans
plant atherosclerosis, collectively termed 'syndromes of accelerated a
therosclerosis', have been the focus of significant clinical and exper
imental research. Limitations of clinical studies have forced emphasis
onto experimental animal models for the purpose of determinining path
ophysiology and evaluation of potential therapeutic strategies. Howeve
r, the apparent failure of many in vivo animal models to predict inter
ventional outcome in humans has raised doubt over their suitability as
models of these pathophysiological states. Similar criticism has befa
llen the use of in vitro techniques for elucidating pathophysiology of
the cellular elements. An awareness of the shortcomings of the variou
s experimental models in use would therefore seem prerequisite both to
a more critical evaluation of data generated from their use, and to t
he development of truly effective therapeutic strategies for humans.